Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Amresh Kumar, Amit Ladha, Ankita Choudhury, Abu Md Ashif Ikbal, Bedanta Bhattacharjee, Tanmay Das, Gaurav Gupta, Chhavi Sharma, Adity Sarbajna, Subhash C Mandal, Manabendra Dutta Choudhury, Nahid Ali, Petr Slama, Nima Rezaei, Partha Palit & Onkar Nath Tiwari. (2022) The chimera of S1 and N proteins of SARS-CoV-2: can it be a potential vaccine candidate for COVID-19?. Expert Review of Vaccines 21:8, pages 1071-1086.
Read now
Read now
Articles from other publishers (3)
Kattlyn Laryssa Candido, Caio Ricardo Eich, Luciana Oliveira de Fariña, Marina Kimiko Kadowaki, José Luis da Conceição Silva, Alexandre Maller & Rita de Cássia Garcia Simão. (2022) Spike protein of SARS-CoV-2 variants: a brief review and practical implications. Brazilian Journal of Microbiology 53:3, pages 1133-1157.
Crossref
Crossref
Satoshi Iwata, Takuhiro Sonoyama, Akari Kamitani, Risa Shibata, Tomoyuki Homma, Shinya Omoto, Kenji Igarashi & Mari Ariyasu. (2022) Phase 1/2 clinical trial of COVID-19 vaccine in Japanese participants: A report of interim findings. Vaccine 40:27, pages 3721-3726.
Crossref
Crossref
Satoshi Iwata, Takuhiro Sonoyama, Akari Kamitani, Risa Shibata, Tomoyuki Honma, Shinya Omoto, Kenji Igarashi & Mari Ariyasu. (2022) Phase 1/2 Clinical Trial of COVID-19 Vaccine in Japanese Participants: A Report of Interim Findings. SSRN Electronic Journal.
Crossref
Crossref